secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vivos Therapeutics, Inc. (VVOS)
CIK:        0001716166
Form:       8-K
Filed at:   2024-09-17T23:59:59+00:00
Accession:  0001493152-24-036852
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.08
LLM model:  deepseek-v4-flash:cloud@v2

Vivos Therapeutics sets 2024 Annual Meeting for Nov 26; Oct 4 record date; Sep 27 deadline for proposals
--------------------------------------------------------------------------------

- 2024 Annual Meeting scheduled for Tuesday, November 26, 2024.
- Record date for voting set at close of business on October 4, 2024.
- Stockholder proposals under Rule 14a-8 must be received by September 27, 2024.
- Director nominations and non-proxy proposals also due by September 27, 2024.
- Address for submissions: Corporate Secretary, Vivos Therapeutics, Inc., 7921 Southpark Plaza, Suite 210, Littleton, CO 80120.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1716166/000149315224036852/0001493152-24-036852-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1716166/000149315224036852/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-036852

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer